Stocklytics Platform
Asset logo for symbol TNDM
Tandem Diabetes Care
TNDM50
$42.40arrow_drop_down0.84%-$0.36
Asset logo for symbol TNDM
TNDM50

$42.40

arrow_drop_down0.84%

AI Deep-Learning Forecast (TNDM)

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Tandem Diabetes Care (TNDM) Stocklytics Forecast

Tandem Diabetes Care Inc (TNDM) is an innovative medical device company that specializes in the design, development, and commercialization of advanced insulin delivery systems for people with diabetes. With its cutting-edge technology and commitment to improving the lives of patients, Tandem Diabetes Care is well-positioned for growth in the fast-growing diabetes management market.
The company's flagship product is the Tandem Diabetes Care insulin pump, which offers a convenient and personalized way for patients to manage their insulin delivery. The pump utilizes advanced algorithms and wireless technology to automate insulin dosing, making it easier for patients to maintain stable blood glucose levels. This advanced technology not only improves patient outcomes but also reduces the burden of daily diabetes management.
add Tandem Diabetes Care  to watchlist

Keep an eye on Tandem Diabetes Care

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Tandem Diabetes Care (TNDM) stock?

Analysts have set a target price of $42.33 for Tandem Diabetes Care (TNDM), based on forecasts from 24 analysts. The predicted price range extends from a high of $75 to a low of $21. This represents a potential increase of up to 76.89% and a decrease of -50.47% from the current price of $42.4. These forecasts are as of 2023 May 05.
help

What are the analyst ratings for Tandem Diabetes Care (TNDM) stock?

The analyst ratings for Tandem Diabetes Care (TNDM) are distributed as follows: 1 analysts recommend buying, 5 have a neutral stance, and 1 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering Tandem Diabetes Care .
help

What is the AI price prediction for Tandem Diabetes Care (TNDM) stock?

The AI price prediction model, leveraging machine-learning techniques, forecasts that Tandem Diabetes Care (TNDM) stock could reach $39.22 by 2024 Sep 30. This prediction indicates a potential price change of -7.49%. The forecast has a lifetime of 30 days, culminating on the target date provided. The prediction was made on 2024 Sep 06.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media